您的当前位置:首页 > 行业数据 > 2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况
图片属性
图片格式:PNG 图片大小:114KB 图片尺寸:2355*905
同报告图片
 / 4
2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况_第1页
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
2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况_第2页
2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况_第3页
fCDlubTku70gfCDluILlnLrop4TmqKHvvIjnmb7kuIfnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMCB8IDQyLDQzMC40ICAgICAgICAgICAgIHwKfCAyMDI2IHwgODAsNDczLjUgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaVGVjaG5hdmlv77yM5Y2O5a6J6K+B5Yi456CU56m25omA
2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况_第4页
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
2021年上半年Moderna以及BioNTech新冠疫苗销售收入增长情况_第5页
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
所属报告: 百克生物-差异化产品构筑业绩护城河带疱疫苗有望拉动成长-211224(42页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠